1. Home
  2. BOKF vs RGEN Comparison

BOKF vs RGEN Comparison

Compare BOKF & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOKF
  • RGEN
  • Stock Information
  • Founded
  • BOKF 1910
  • RGEN 1981
  • Country
  • BOKF United States
  • RGEN United States
  • Employees
  • BOKF N/A
  • RGEN N/A
  • Industry
  • BOKF Major Banks
  • RGEN Medical/Dental Instruments
  • Sector
  • BOKF Finance
  • RGEN Health Care
  • Exchange
  • BOKF Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • BOKF 6.0B
  • RGEN 6.5B
  • IPO Year
  • BOKF N/A
  • RGEN N/A
  • Fundamental
  • Price
  • BOKF $110.92
  • RGEN $113.54
  • Analyst Decision
  • BOKF Hold
  • RGEN Buy
  • Analyst Count
  • BOKF 10
  • RGEN 10
  • Target Price
  • BOKF $114.30
  • RGEN $163.78
  • AVG Volume (30 Days)
  • BOKF 193.4K
  • RGEN 700.4K
  • Earning Date
  • BOKF 10-20-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • BOKF 2.06%
  • RGEN N/A
  • EPS Growth
  • BOKF 17.28
  • RGEN N/A
  • EPS
  • BOKF 8.36
  • RGEN N/A
  • Revenue
  • BOKF $2,074,957,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • BOKF $6.67
  • RGEN $16.74
  • Revenue Next Year
  • BOKF $7.10
  • RGEN $13.86
  • P/E Ratio
  • BOKF $13.26
  • RGEN N/A
  • Revenue Growth
  • BOKF 4.66
  • RGEN 8.73
  • 52 Week Low
  • BOKF $85.08
  • RGEN $102.97
  • 52 Week High
  • BOKF $121.58
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • BOKF 59.08
  • RGEN 40.89
  • Support Level
  • BOKF $109.89
  • RGEN $117.18
  • Resistance Level
  • BOKF $113.32
  • RGEN $122.71
  • Average True Range (ATR)
  • BOKF 2.06
  • RGEN 4.36
  • MACD
  • BOKF -0.29
  • RGEN -0.55
  • Stochastic Oscillator
  • BOKF 48.66
  • RGEN 6.59

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: